Showing results (181-190 of 220) with videos related to
Sort By:
Pageof 22
Current Opinion in Investigational Drugs (London, England : 2000)|April 9, 2005
Conivaptan YamanouchiSheila A DoggrellExpert Opinion on Pharmacotherapy|July 15, 2005
Pegaptanib: the first antiangiogenic agent approved for neovascular macular degenerationSheila A DoggrellExpert Opinion on Pharmacotherapy|June 7, 2005
Has the controversy over the use of calcium channel blockers in coronary artery disease been resolved?Sheila A DoggrellExpert Opinion on Therapeutic Targets|June 7, 2005
Bradykinin B2 receptors--a target in diabetic nephropathySheila A DoggrellTimely Topics in Medicine. Cardiovascular Diseases|March 10, 2006
Vascular medicine in Australia and Germany: highlights from the First International Conference in Vascular Medicine, held August 26-28, 2005, in Melbourne, AustraliaSheila A DoggrellExpert Opinion on Investigational Drugs|May 11, 2005
Farnesoid X receptor agonism -- a new approach to the treatment of cholesterol gallstone diseaseSheila A DoggrellExpert Opinion on Pharmacotherapy|May 7, 2013
Percutaneous coronary intervention with drug-eluting stents or coronary artery bypass surgery in subjects with type 2 diabetesSheila A DoggrellExpert Opinion on Pharmacotherapy|August 12, 2017
No cardiovascular benefit with evacetrapib - is this the end of the road for the 'cetrapibs'?Sheila A DoggrellExpert Opinion on Investigational Drugs|September 8, 2020
Remdesivir, a remedy or a ripple in severe COVID-19?Sheila A DoggrellPageof 22